Administrative Core
Administrative Core
批准号:
8278876
负责人:
David J Rawlings
金额:
$6.3万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-07 至 2017-07-31
关键词:
Advisory CommitteesAnimal ModelBasic ScienceChildClinicalCommunicationCommunitiesDevelopmentEnsureEthicsExpenditureFred Hutchinson Cancer Research CenterGoalsGrantHumanHuman ResourcesImmunologic Deficiency SyndromesInstitutionLaboratoriesLeadLinkMarrowOccupational activity of managing financesPennsylvaniaPrincipal InvestigatorProceduresResearchResearch InfrastructureResearch InstituteResearch PersonnelResourcesSCID MiceServicesSiteSite VisitTechnologyTeleconferencesTranslational ResearchUnited States National Institutes of HealthUniversitiesViral GenesWashingtonWorkanticancer researchexperiencegene therapymeetingsmembernovel strategiesoperationprogramsstem cell therapysuccessvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Development of an integrated FV-based gene therapy for SCID-Xl requires efficient integration of our
proposed basic and translafional research efforts and supporting core services across five institufions
(Seattle Children's Research Institute (SCRl); Fred Hutchinson Cancer Research Institute (FHCRC);
Washington State University (WSU); University of Washington (UW) and University of Pennsylvania (U of
Penn)). The overall goal of the Administrative Core is to facilitate success by coordinafion of the
administrative, fiscal and organizafional aspects of our PPG program. Specifically, the Core will: provide
administrative support for management of financial resources, expenditure and budgetary tracking;
coordinate meefings and communicafions and disseminate key informafion among invesfigators and with the
larger scientific community; orchestrate an annual External Advisory Committee site visit; and ensure that
the highest ethical standards are met in conducting our studies. Core activities will interface with scientific
and administrafive staff at all collaborafing institutions and provide a bridge between these institutions to
ensure smooth operafion of the program. Our administrative staff is already adept at handling the
complexities created by such a combined program. Dr. Rawlings and Dr. Kiem have been collaborating for
more than 5 years on gene therapy related studies. They will work together to lead Core A and thereby
effectively direct and coordinate overall project work flow. To accomplish this, key Core A personnel will be
located at each of their respective institutions, SCRl and FHCRC.
RELEVANCE:
Successful development of FV vector-based gene therapy for SCID-Xl requires integration of our studies
across five insfitutions. The Administrafive Core will facilitate success by coordination of the administrafive,
fiscal and organizafional aspects of our program. Core acfivifies will interface with scientific and
administrative staff at all institufions to provide a bridge ensuring smooth operation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An integrated strategy to define the functional and synergistic impact of T1D causal variants
-
批准号:9227381
-
项目类别:
-
资助金额:$441.14万
-
财政年份:2016
-
负责人:David J Rawlings
-
依托单位:
Lentiviral Gene Therapy of X-Linked Agammaglobulinemia
-
批准号:8825754
-
项目类别:
-
资助金额:$8.78万
-
财政年份:2014
-
负责人:David J Rawlings
-
依托单位:
Pre-clinical Modeling of Foamy Viral gene Therapy for Murine and Human SCID-X1
-
批准号:8278864
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2012
-
负责人:David J Rawlings
-
依托单位:
B cell function and phenotype as predictors of therapeutic response to rituximab
-
批准号:8044994
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2010
-
负责人:David J Rawlings
-
依托单位:
Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome
-
批准号:7576150
-
项目类别:
-
资助金额:$99.39万
-
财政年份:2008
-
负责人:David J Rawlings
-
依托单位:
Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome
-
批准号:7463332
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2008
-
负责人:David J Rawlings
-
依托单位:
Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome
-
批准号:8228037
-
项目类别:
-
资助金额:$71.55万
-
财政年份:2008
-
负责人:David J Rawlings
-
依托单位:
Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome
-
批准号:7772315
-
项目类别:
-
资助金额:$80.36万
-
财政年份:2008
-
负责人:David J Rawlings
-
依托单位:
Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome
-
批准号:8029506
-
项目类别:
-
资助金额:$71.55万
-
财政年份:2008
-
负责人:David J Rawlings
-
依托单位:
Interdisciplinary Training in Genome Engineering (Component 10 of 11)TL1
-
批准号:7503426
-
项目类别:
-
资助金额:$4.95万
-
财政年份:2007
-
负责人:David J Rawlings
-
依托单位:
Interdisciplinary Training in Genome Engineering (Component 10 of 11)TL1
-
批准号:7903234
-
项目类别:
-
资助金额:$10.28万
-
财政年份:2007
-
负责人:David J Rawlings
-
依托单位:
Core--Immune Function Studies
-
批准号:7478454
-
项目类别:
-
资助金额:$9.66万
-
财政年份:2007
-
负责人:David J Rawlings
-
依托单位:
Cell and Virus CORE
-
批准号:7600770
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2007
-
负责人:David J Rawlings
-
依托单位:
Interdisciplinary Training in Genome Engineering(Component 10 of 11) RL9
-
批准号:7687345
-
项目类别:
-
资助金额:$16.56万
-
财政年份:2007
-
负责人:David J Rawlings
-
依托单位:
Interdisciplinary Training in Genome Engineering
-
批准号:7466773
-
项目类别:
-
资助金额:$4.95万
-
财政年份:2007
-
负责人:David J Rawlings
-
依托单位:
Gene Repair in Murine Hematopoietic Stem Cells (Component 6 of 11)
-
批准号:7503424
-
项目类别:
-
资助金额:$45.5万
-
财政年份:2007
-
负责人:David J Rawlings
-
依托单位:
Cell and Virus CORE
-
批准号:7903236
-
项目类别:
-
资助金额:$82.21万
-
财政年份:2007
-
负责人:David J Rawlings
-
依托单位:
Interdisciplinary Training in Genome Engineering (Component 10 of 11)TL1
-
批准号:7687346
-
项目类别:
-
资助金额:$5.17万
-
财政年份:2007
-
负责人:David J Rawlings
-
依托单位:
Gene Repair in Murine Hematopoietic Stem Cells (Component 6 of 11)
-
批准号:7661520
-
项目类别:
-
资助金额:$45.5万
-
财政年份:2007
-
负责人:David J Rawlings
-
依托单位:
Gene Repair in Murine Hematopoietic Stem Cells (Component 6 of 11)
-
批准号:7903222
-
项目类别:
-
资助金额:$45.05万
-
财政年份:2007
-
负责人:David J Rawlings
-
依托单位:
海外基金